SCHEMBL9008282

SCHEMBL9008282

CCCCCCC=CCC(O)CCCCCCC

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.76
FFAR4 Q5NUL3 1/20 0.76
FAAH O00519 5/20 0.64
NFKB1 P19838 1/20 0.58
NFKB2 Q00653 1/20 0.58
RELA Q04206 1/20 0.58
TRPV1 Q8NER1 2/20 0.47
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
CYP3A4 P08684 1/20 0.46
TERT O14746 3/20 0.46
MAPT P10636 2/20 0.46
BLM P54132 2/20 0.46
HSD17B10 Q99714 2/20 0.46
GPR84 Q9NQS5 2/20 0.46
FABP4 P15090 2/20 0.46
GMNN O75496 1/20 0.46
USP2 O75604 1/20 0.46
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10875401 1.00 FFAR1 (0.76) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL20021280 1.00 FFAR1 (0.76) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL7204568 1.00 FFAR1 (0.76) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL25132301 1.00 FFAR1 (0.76) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL23092269 1.00 FFAR1 (0.76) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL23092271 1.00 FFAR1 (0.76) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL23092270 1.00 FFAR1 (0.76) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL23092225 1.00 FFAR1 (0.76) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL14456195 1.00 FFAR1 (0.76) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL14890377 1.00 FFAR1 (0.76) FFAR1FFAR4FAAHNFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5491152-A Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-02-13 US disclosed